N. Yamane

发表

Determination of Branched β-Cyclodextrin–Prostaglandin Complexes Using Electrospray Ionization Mass Spectrometry

Y. Okada, Y. Nishi, C. Honda, 2008 .

Fully validated LCMS bioanalysis of Bevacizumab in human plasma using nano-surface and molecular-orientation limited (nSMOL) proteolysis.

T. Shimada, A. Hamada, N. Iwamoto, 2016, Drug metabolism and pharmacokinetics.

The development of the validated LCMS bioanalysis of trastuzumab in human plasma using a selective detection method for complementarity-determining regions of monoclonal antibodies: nano-surface and molecular-orientation limited (nSMOL) proteolysis

T. Shimada, A. Hamada, N. Iwamoto, 2015 .

Microdose clinical trial: quantitative determination of nicardipine and prediction of metabolites in human plasma.

Yuichi Sugiyama, Yuji Kumagai, Zenzaburo Tozuka, 2009, Drug metabolism and pharmacokinetics.

Clinical Relevance of Liquid Chromatography Tandem Mass Spectrometry as an Analytical Method in Microdose Clinical Studies

Toshihiko Ikeda, Kazuya Maeda, Yuichi Sugiyama, 2011, Pharmaceutical Research.

Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.

Yuichi Sugiyama, Yuji Kumagai, Y. Sugiyama, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Preparation and characterization of 6I,6n-di-O-(L-fucopyranosyl)-beta-cyclodextrin (n=II-IV) and investigation of their functions.

Y. Nishi, T. Tanimoto, N. Yamane, 2007, Carbohydrate research.

High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples.

S. Oka, H. Gatanaga, K. Tsuchiya, 2018, Biomedical chromatography : BMC.

Identification of the Rate‐Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

Y Kumagai, K. Maeda, Y. Sugiyama, 2011, Clinical pharmacology and therapeutics.

Microdosing clinical study to clarify pharmacokinetic and pharmacogenetic characteristics of atorvastatin in Japanese hypercholesterolemic patients.

K. Maeda, H. Kusuhara, Y. Sugiyama, 2019, Drug metabolism and pharmacokinetics.

Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p‐Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs

Kazuya Maeda, Yuichi Sugiyama, Miyuki Kimura, 2013, Journal of clinical pharmacology.

Cost-effectiveness analysis of microdose clinical trials in drug development.

Toshihiko Ikeda, Kazuya Maeda, Yuichi Sugiyama, 2013, Drug metabolism and pharmacokinetics.

Microdose study of a P‐glycoprotein substrate, fexofenadine, using a non‐radioisotope‐labelled drug and LC/MS/MS

Y Kumagai, Y. Sugiyama, T. Fujita, 2010, Journal of clinical pharmacy and therapeutics.